Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities
J Investig Allergol Clin Immunol
.
2024 Nov 27:0.
doi: 10.18176/jiaci.1034.
Online ahead of print.
Authors
B Mascaró-Hereza
1
2
,
D Loli-Ausejo
1
2
,
A Valero
1
2
3
,
E Arismendi
3
4
,
I Bobolea
1
2
3
Affiliations
1
Department of Allergy, Hospital Clínic, Barcelona, Spain.
2
IDIBAPS Clinical and Experimental Respiratory Immunology (IRCE), August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
3
CIBER of Respiratory Diseases (CIBERES), Health Institute Carlos III.
4
Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
PMID:
39607423
DOI:
10.18176/jiaci.1034
No abstract available
Keywords:
Biologics; Comorbidities; Monoclonal antibodies; Severe asthma; Treatment.